Medical Imaging in Novel Drug Development-JuniperPublishers
Cancer Therapy & Oncology - Juniper Publishers Abstract Medical Imaging is now being used extensively, in fact more than ever, for clinical trials for a new drug development. Medical imaging can be used through any of the available imaging modalities, including quantitative imaging with the help of CT, MRI or hybrid PET-CT. Much time and money can be saved in not proceeding with a clinical trial as imaging can predict fairly well and early about the efficacy of a compound for the disease process in its evaluation as a “Go-No Go” approach. FDA and other regulatory authorities also believe that medical imaging is a critical component in its Critical Path Opportunity List of 2006. It is significant to note that pharmaceutical companies and CROs employ imaging as its important tool to quantify matrix for its justification of introducing a new drug, but standardization in terms of patient positioning or the central reads have to be justified against in